EcoDrugPlus

Solute Carrier Family 6 Member 1

Ensembl ID : ENSSTUG00000047060
Gene Symbol: SLC6A1
3 Cross references
203 Possible Orthologues:

Solute Carrier Family 6 Member 2

Ensembl ID : ENSSTUG00000043761
Gene Symbol: SLC6A2
3 Cross references
195 Possible Orthologues:

Solute Carrier Family 6 Member 2

Ensembl ID : ENSSTUG00000049161
Gene Symbol: SLC6A2
3 Cross references
197 Possible Orthologues:

Solute Carrier Family 6 Member 3

Ensembl ID : ENSSTUG00000035083
Gene Symbol: SLC6A3
3 Cross references
159 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSSTUG00000050247
Gene Symbol: SLC9A3
1 Cross references
222 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSSTUG00000035842
Gene Symbol: SLC9A3
3 Cross references
222 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSSTUG00000019431
Gene Symbol: SLC9A3
3 Cross references
222 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSSTUG00000050996
Gene Symbol: SSTR1
3 Cross references
152 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSSTUG00000030944
Gene Symbol: SSTR1
3 Cross references
151 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSSTUG00000027893
Gene Symbol: SSTR2
3 Cross references
186 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSSTUG00000011374
Gene Symbol: SSTR2
3 Cross references
186 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSSTUG00000010587
Gene Symbol: SSTR2
3 Cross references
188 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).